Clinical Trials Directory

Trials / Completed

CompletedNCT00555282

Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of Two Different Central Venous Catheters (CVC)

Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of a Standard Central Venous Catheter (CVC) in Comparison to a Coated CVC

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
680 (actual)
Sponsor
B. Braun Melsungen AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The use of these catheters is associated with infectious complications that are an important iatrogenic source of morbidity and mortality. Certofix® protect is a catheter with a surface modified in order to reduce colonization by bacteria. This clinical trial is performed to compare the safety and efficacy of the coated central venous catheter, Certofix® protect, with that of the non-coated standard catheter Certofix®.

Detailed description

Central venous catheters are an essential part of patient management in the ICU (Intensive Care Unit). The use of these catheters is associated with infectious complications that are an important iatrogenic source of morbidity and mortality. Many catheters become colonized with bacteria but only a proportion of colonised catheters go on to cause bacteriemia and sepsis. It is currently impossible to prospectively identify which of the catheters will become colonized and lead to sepsis. Various types of antiseptic or antimicrobial vascular catheter coatings have been developed. Studies showed that the coated catheters were effective in limiting the catheter colonization rate and that they may decrease the risk of catheter-related bloodstream infections. The "Certofix protect" was developed by B.Braun to reduce the risk of catheter related infections. It is a catheter with a modified surface that consists of a high molecular weight polymer which is non-covalently linked to the polyurethane catheter material. This clinical trial is performed to compare the safety and efficacy of the coated central venous catheter, Certofix® protect, with that of the non-coated standard catheter Certofix®.

Conditions

Interventions

TypeNameDescription
DEVICEcentral venous cathetercoated central venous catheter
DEVICEcentral venous catheterstandard central venous catheter

Timeline

Start date
2005-11-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2007-11-08
Last updated
2010-02-05

Locations

2 sites across 1 country: Czechia

Source: ClinicalTrials.gov record NCT00555282. Inclusion in this directory is not an endorsement.